Adaptation of a Transdiagnostic Behavioral Activation Telehealth Group for Autistic Adults
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 6
- 试验地点
- 2
- 主要终点
- Change in Clinician Global Impairment rating
研究概览
简要总结
The purpose of this study is to evaluate the feasibility, acceptability and effectiveness of a telehealth Group Behavioral Activation Therapy (GBAT) for autistic adults.
详细描述
Detailed Description: This study is being done to demonstrate the feasibility, acceptability and effectiveness of a telehealth Group Behavioral Activation Therapy (GBAT) for autistic adults. GBAT is intended to help adults manage stress, anxiety, down moods, and anger. Similar programs have been shown to be effective in other contexts but has not yet been used for autistic adults or delivered via telehealth. Because this is a new intervention, the investigators are interested in learning 1) whether GBAT can be done with autistic adults (feasibility), 2) what autistic adults think about GBAT (acceptability), and 3) whether GBAT is effective for helping autistic adults cope with their feelings. Results from this study will be used to inform adaptation to the intervention and planning for future studies to further explore its effectiveness. For this initial feasibility study, 8 autistic adults (18-40 years old) with VIQ and NVIQ>85, reading composite at least 6th grade level and elevated symptoms of depression, anxiety or anger will be recruited.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
盲法说明
This is an open trial feasibility study
入排标准
- 年龄范围
- 18 Years 至 40 Years（Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Be 18-40 years old
- •Have a confirmed diagnosis of Autism Spectrum Disorders (ASD).
- •Have access to a device (e.g., computer with a webcam or smartphone) in order to complete online surveys and participate in the telehealth videoconferencing sessions
- •*Have a VIQ and NVIQ of 85 or above
- •*Have at least a 6th grade reading composite
- •*Have elevated symptoms of depression, anxiety or anger. This will be determined based on scoring above the borderline or mild threshold on at least one of 3 screening measures (MINI; ASR; DASS-21).
排除标准
- •Are younger than 18 years old, or older than 40 years old (Children are excluded because the focus is on adapting GBAT for adults; Individuals above 40 are excluded to restrict the adult focus to young adults that are more likely to be in similar life stages).
- •Do not have an ASD diagnosis (because the study as the purpose of the current research is to examine GBAT's feasibility with autistic adults).
- •Both VIQ and NVIQ below 85 OR less than 6th grade reading level
- •Do not have elevated scores of depression, anxiety, or anger on the symptom screening measures.
- •Are unable to understand English fluently (because the instruments being investigated are currently only validated in English and the intervention will be delivered in English).
- •Are currently enrolled in another behavioral therapy or psychotherapy targeting depression,
- •the PI's clinical judgment that it would not be in the adult's best interest to be enrolled (e.g., due to factors that may affect their engagement or comfort in the group).
结局指标
主要结局
Change in Clinician Global Impairment rating
时间窗: 10 week study period;
The CGI is a 7 point scale on which the clinician rates the severity of the client's impairment. The scale ranges from 1 (Normal, not at all ill) to 7 Extremely Ill; higher scores indicate more impairment.
Change in symptoms on the Adult Self Report (ASR)
时间窗: 10 week study period; 4 week post-treatment
The ASR is a an assessment of adult psychopathology (e.g., anxiety, depression symptoms). Most of the items are on a 3 point scale including: (0) Not true, (1) Somewhat or sometimes true, and (2) Very often or often true.
次要结局
- Change in Behavioral Activation for Depression Scale(10 week study period; 4 week post-treatment)
- Change in Adaptive Behavior Assessment System - 3 (ABAS-3)(10 week study period)
- Change in symptoms on the Depression Anxiety Stress Scales-21(10 week study period; 4 week post-treatment)
- Change in distress on Patient Health Questionnaire (PHQ-9)(10 week study period)
- Change in anxiety symptoms on the Generalized Anxiety Disorder Questionnaire (GAD-7)(10 week study period)
- Change in Idiographic target goals(10 week study period; 4 week post-treatment)
研究者
Vanessa H. Bal, PhD
Karmazin & Lillard Chair in Adult Autism; Associate Professor
Rutgers, The State University of New Jersey